1. Home
  2. METC vs JANX Comparison

METC vs JANX Comparison

Compare METC & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • METC
  • JANX
  • Stock Information
  • Founded
  • METC 2015
  • JANX 2017
  • Country
  • METC United States
  • JANX United States
  • Employees
  • METC N/A
  • JANX N/A
  • Industry
  • METC Coal Mining
  • JANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • METC Energy
  • JANX Health Care
  • Exchange
  • METC Nasdaq
  • JANX Nasdaq
  • Market Cap
  • METC 1.6B
  • JANX 1.4B
  • IPO Year
  • METC 2017
  • JANX 2021
  • Fundamental
  • Price
  • METC $23.94
  • JANX $24.68
  • Analyst Decision
  • METC Strong Buy
  • JANX Strong Buy
  • Analyst Count
  • METC 3
  • JANX 10
  • Target Price
  • METC $21.67
  • JANX $79.50
  • AVG Volume (30 Days)
  • METC 2.9M
  • JANX 645.3K
  • Earning Date
  • METC 11-03-2025
  • JANX 11-05-2025
  • Dividend Yield
  • METC 2.27%
  • JANX N/A
  • EPS Growth
  • METC N/A
  • JANX N/A
  • EPS
  • METC N/A
  • JANX N/A
  • Revenue
  • METC $625,919,000.00
  • JANX $439,000.00
  • Revenue This Year
  • METC $0.82
  • JANX N/A
  • Revenue Next Year
  • METC $19.59
  • JANX $591.60
  • P/E Ratio
  • METC N/A
  • JANX N/A
  • Revenue Growth
  • METC N/A
  • JANX N/A
  • 52 Week Low
  • METC $5.90
  • JANX $21.97
  • 52 Week High
  • METC $28.40
  • JANX $71.71
  • Technical
  • Relative Strength Index (RSI)
  • METC 50.39
  • JANX 52.74
  • Support Level
  • METC $24.84
  • JANX $23.62
  • Resistance Level
  • METC $28.40
  • JANX $25.35
  • Average True Range (ATR)
  • METC 1.69
  • JANX 1.13
  • MACD
  • METC -0.29
  • JANX 0.18
  • Stochastic Oscillator
  • METC 14.01
  • JANX 67.92

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: